http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-750330-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0b4dd29891f892c9208aac43470acd3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
filingDate 1953-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d694b0a753ce024a784d0f1ae99879
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b94f8554af17597db90aabcb69332a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe59cc20fe64b0334ee6546287d62ac6
publicationDate 1956-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-750330-A
titleOfInvention Improvements in or relating to the preparation of steroid substances
abstract 3-Keto-2-iodo-D 4-steroids and 3-keto-D 4-steroids are prepared by treatment of 3-keto-2:4-dibromoallosteroids with an alkali metal iodide soluble in the reaction medium, in the presence of an organic iodine compound which under the conditions of the reaction reacts with hydrogen iodide to form iodine and thereafter reducing the 3-keto-2-iodo-D 4-steroids produced. The organic iodine compound is normally generated in situ by the addition of an organic substance having an active chlorine or bromine atom which reacts with alkali metal iodide with the replacement of chlorine or bromine by iodine, e.g. benzyl chloride, allyl bromide; the preferred compounds are a -halogeno ketones of formula R3.CO.CHX.R4, where R3 is an alkyl radical containing from 1-4 carbon atoms, R4 is an alkyl radical containing from 1-3 carbon atoms and X is Cl, Br or I. Specified solvents are acetone, methyl ethyl ketone, t.-butanol, tetrahydrofuran and methyl cyanide. In examples: (1) sodium iodide and bromoacetone or allyl bromide are refluxed in acetone, 17a :21 - diacetoxy - 2:4 - dibromo - 3:11:20-triketoallopregnane added and after further refluxing, the mixture is poured into aqueous sodium thiosulphate and extracted with methylene chloride; the residue after evaporation of the solvent (crude 2-iodosteroid), is reduced with chromous chloride solution to yield cortisone diacetate; (2) as in (1) 21 - acetoxy - 17a - hydroxy - 2:4 - dibromo - 3:11:20 - triketoallopregnane is converted to cortisone 21-acetate; (3) cortisone diacetate is prepared as in (1) using bromomethyl ethyl ketone in methyl ethyl ketone. Comparative experiments (without the addition of an activated halogen compound), are also described. Specifications 693,991, 746,488 and 748,779 are referred to.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2959603-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2959602-A
priorityDate 1953-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447582325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414872497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448906802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408

Total number of triples: 56.